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Abstract 
Cell-derived membrane vesicles that are released in biofluids, like blood or saliva, are 
emerging as potential non-invasive biomarkers for diseases, such as cancer. Techniques 
capable of measuring the size and concentration of membrane vesicles directly in biofluids are 
urgently needed. Fluorescence Single Particle Tracking microscopy has the potential of doing 
exactly that, by labelling the membrane vesicles with a fluorescent label and analysing their 
Brownian motion in the biofluid. However, unbound dye in the biofluid can cause high 
background intensity that strongly biases the fluorescence Single Particle Tracking size and 
concentration measurements. While such background can be avoided with light sheet 
illumination, current set-ups require specialty sample holders that are not compatible with 
high-throughput diagnostics. Here, a microfluidic chip with integrated light sheet illumination 
is reported, and accurate fluorescence Single Particle Tracking size and concentration 
measurements of membrane vesicles in cell culture medium and in interstitial fluid collected 
from primary human breast tumours are demonstrated. 
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Introduction 
The relation between specific types of cell-derived membrane vesicles (MVs) in body fluids 
and disease progression, e.g. tumour growth and metastasis, is a topic that receives a lot of 
attention nowadays 1-6. The size, origin and concentration of cell-derived MVs could entail 
clinically relevant signatures with diagnostic and prognostic value 2, 5, 7. Thus, substantial 
efforts have gone into evaluating and developing techniques suitable for submicron MV 
characterization in terms of specificity, size and concentration 8. Specifically, due to a lack of 
standardized isolation and purification protocols and in order to avoid manipulation artefacts, 
techniques capable of performing MV characterization directly in body fluids are urgently 
needed 2, 9, 10. 
Fluorescence Single Particle Tracking (fSPT) was recently shown to be the first technique 
capable of accurately measuring the size distribution and number concentration of 
fluorescently labelled nanoparticles in undiluted biofluids, such as whole blood 11, 12. However, 
being based on epi-fluorescence microscopy, a limitation of the technique is limited contrast 
due to fluorescence coming from out-of-focus particles or unbound fluorescent dye, as 
illustrated in Figure 1a. Especially the latter aspect can be problematic for fSPT 
characterization of MVs that require staining with fluorescent labels targeted against specific 
membrane markers to detect MV subpopulations. As the concentration of MVs in e.g. a 
patient sample is unknown a priori, a surplus of labelled antibodies has to be added in order to 
be certain that all vesicles will be stained. This will typically result in a substantial fraction of 
unbound fluorescent labels in the sample medium and a concomitant decrease in contrast. 
Thus, smaller (dimmer) particles are more difficult to detect, resulting in an underestimation 
of the number concentration and a biased size distribution. This is especially of importance 
for a correct characterization of the smaller types of MVs, such as exosomes, with a size 
below 100 nm 10, 13. 
To enable high-throughput diagnostics of MVs in biofluids, we created a mass producible 
microfluidic chip with integrated light sheet illumination for fSPT size and concentration 
measurements of submicron MVs that are fluorescently labelled directly in the biofluid 
without the need for isolation or purification steps. Light sheet illumination presents an 
attractive alternative to conventional epi-illumination as it combines superior contrast with 
real-time imaging, as is required to capture the MV’s fast Brownian motion 14-16. Although 
light sheet illumination has mainly been applied to mesoscopic imaging set-ups for 
developmental biology 17-20, some reports demonstrate its usefulness for high-resolution 
imaging applications as well 15, 16, 21, 22. As illustrated in Figure 1a, this requires two objective 
lenses positioned perpendicular to one another in very close proximity, one for creating the 
light sheet, the other one for imaging. This has been shown to be possible for fSPT 
experiments in combination with custom made sample holders having two high-quality 
optical windows for illumination and imaging 14-16. However, as they are difficult and 
expensive to manufacture 23, they are not suitable for high-throughput diagnostic assays for 
which inexpensive disposable sample holders are preferred to avoid extensive cleaning 
procedures and sample contamination. 
Here, we realize for the first time light sheet illumination in a mass-manufacturable 
microfluidic chip by coupling laser light into a planar waveguide structure in which a 
microchannel is provided, containing the sample. We show that the contrast with which the 
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nanospheres can be visualized, improves substantially compared to classic epi-fluorescence 
illumination, close to what has been achieved on dedicated light sheet microscopes. To 
demonstrate the potential of the microfluidic chip as a diagnostic tool, fSPT measurements are 
performed of MVs in cell culture medium and in interstitial fluid collected from primary 
human breast tumours. Because of the high background intensity coming from unbound 
marker molecules, the on-chip light sheet illumination is found to be essential for correct MV 
characterization. 
 
Experimental Section 
fSPT size distribution and number concentration measurements 
fSPT measurements can be used to determine the number concentration and size distribution 
of particles undergoing Brownian motion in a dispersion 11, 12. Briefly, first a movie is 
recorded of the diffusing particles at a fixed z-position and their motion trajectories are 
determined, using image processing 24. From the mean square displacement, a diffusion 
coefficient can be estimated for each individual trajectory. This leads to a distribution of 
diffusion coefficients when many particles are analysed. A maximum entropy deconvolution 
step can subsequently be applied to this distribution to reduce sampling noise and improve its 
precision 11. The distribution of diffusion coefficients can be converted to a size distribution 
via the Stokes-Einstein relation. The number concentration can be derived from the 
trajectories as well, since the particle number in each image is known and the observation 
volume can be inherently calibrated from the time that particles appear in focus 12. The fSPT 
experiments for determination of the size and concentration are performed in a silicon chip. 
The microchannel is filled with the dispersion of Alexa Fluor 647 labelled MVs, and the 
objective lens is positioned so that the focal plane coincides with the light sheet. Subsequently, 
10 to 20 independent movies of 10 seconds are recorded at randomly chosen locations in the 
sample, with a frame rate of 22.6-27.6 frames per second, an image acquisition time of 20-30 
ms, an image size of 436-450 pixels in the x-direction and 124-192 pixels in the y-direction, 
and a pixel size of 196 nm. Particle trajectories from all movies are calculated off line 24, and 
pooled before calculation of the size distribution and number concentration. Only trajectories 
of minimally 5 positions are included in the analysis to remove false positives. For both 
illumination types, the size and concentration results were obtained from one and the same 
sample. 
 
Chip fabrication process 
Multiple microfluidic chips with an integrated planar waveguide are simultaneously 
fabricated in one process on 10 cm diameter wafers. Two different types of wafers are used, 
standard silicon wafers and 145 µm thick borosilicate glass wafers. The wafers are first 
cleaned with an O2 plasma in a TepPla 300 plasma system. The clean room process is 
illustrated in Figure S4. First, SU-8 type GM 1060 (Gersteltec Sàrl, Switzerland) mixed with 
6% of the epoxy resin D.E.R.™ 353 (The Dow Chemical Company, Belgium) is spin coated 
on the wafer using a Sawatec LSM 200 coater, to obtain a ~25 µm thick bottom cladding 
layer, followed by soft baking on a Sawatec HP 401 Z hotplate (see Supporting Table 1). 
Next, pure SU-8 type GM 1060 is spin coated on the bottom cladding layer to obtain a ~5 µm 
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thick core layer, again followed by a soft bake step. Finally, SU-8 type GM 1060 mixed with 
6% of the epoxy resin D.E.R.™ 353 is spin coated on the core layer to obtain a ~25 µm thick 
top cladding layer, followed by a final soft bake step. To create the microfluidics, the whole 
3-layer structure is exposed to 270 mJ/cm2 of the i-line (365 nm) of a Karl Suss MA 6 mask 
aligner using a Cr mask. Next, the structure is post exposure baked on a programmable 
hotplate, and developed in a wet bench using propylene glycol methyl ether acetate (PGMEA). 
The wafer is finally diced with a Disco DAD 321 Automatic Dicing Saw, to obtain separate 
microfluidic chips that each contain a planar waveguide and microchannel with in- and outlet 
reservoir. 
 
Isolation, sizing, and labelling of breast cancer cell-line derived MVs 
The MCF-7 breast cancer cell line 25 stably transfected with GFP-Rab27B was maintained at 
37°C and 5% CO2 in Dulbecco’s Modified Eagle Medium (Invitrogen, Belgium) 
supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin. For MV 
production, cells were cultured in DMEM supplemented with 10% Exo-FBS™ (System 
Biosciences, Belgium) for 48 hours. MVs were isolated from the conditioned medium by 
differential centrifugation. Briefly, conditioned cell culture medium was successively 
centrifuged at 300 g for 10 minutes, 3000 g for 10 minutes, and 15000 g for 30 minutes and 
the supernatant was collected after each step. Next, the supernatant was concentrated using a 
Vivaspin 20 with molecular weight cut-off 50 kDa (Sartorius, Belgium) to a volume of about 
5 ml. The MVs were then pelleted by ultracentrifugation (UC) for 70 minutes at 120 000 g, 
washed with phosphate buffered saline (PBS) and again pelleted by UC at 120 000 g for 70 
minutes. Finally the MV pellet was resuspended in 200 µl PBS. After diluting 5× in PBS, the 
MV size distribution was measured by dynamic light scattering measurements at 25°C on a 
Nano-ZS (Malvern, UK), see Figure S5. The MVs were fluorescently labelled by mixing 3 µl 
of the isolated MVs with 6 µl HEPES buffer, 1 µl 10× Annexin V binding buffer (100 mM 
HEPES, 1.4 M NaCl, and 25 mM CaCl2, pH 7.4) and 0.1 µl neat Annexin V Alexa Fluor 647 
(Molecular Probes™, Life Technologies Europe, Belgium). The sample was gently mixed and 
incubated in the dark for 15 minutes at room temperature prior to measurement. 
 
Fluorescent labelling of MVs in tumour interstitial fluid 
Primary breast cancer resection specimens were collected at Ghent University Hospital. 
Written informed consent was obtained from each patient according to the recommendations 
of the local ethics committee. About 0.25 g of clean fresh tissue was cut into small pieces (1-2 
mm3), washed carefully with PBS, and incubated in 1 ml PBS for 1 hour at 37°C in a 
humidified CO2 incubator. The samples were centrifuged 26 at 500 g for 10 minutes and 1500 
g for 20 minutes. Without any further purification, 4 µl of the final supernatant (i.e. tumour 
interstitial fluid) was mixed with 8 µl of Annexin V binding buffer (10 mM HEPES, 140 mM 
NaCl, and 2.5 mM CaCl2, pH 7.4) and 4 µl of Annexin V Alexa Fluor 647 (Invitrogen, 
Belgium). The sample was gently mixed and incubated in the dark for 15 minutes at room 
temperature prior to measurement. Note that size measurements by DLS are not an option due 
to the high protein content and the presence of other light scattering compounds in interstitial 
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fluid. Neither does DLS allow to perform concentration measurements, nor can it detect a 
specific subtype of MVs as can be achieved with fSPT by using labelled antibodies. 
 
Results 
Fabrication of the chip 
To obtain on-chip light sheet illumination, a mass-manufacturable microfluidic chip was 
created according to the design illustrated in Figure 1b. The chip is fabricated on a glass or 
silicon substrate on top of which a planar waveguide structure is created consisting of 3 layers 
of SU-8 that are sequentially deposited by spin coating followed by a soft bake step. The 
refractive index of the bottom and top layer (~25 µm thickness each) is lowered by mixing the 
SU-8 with the epoxy resin D.E.R.™ 353, making these layers suitable as waveguide cladding 
while the middle layer (~5 µm thickness) acts as waveguide core 27. Finally, a microchannel 
of 100 µm width containing in- and outlet reservoirs is created in the SU-8 waveguide using 
standard photolithography (see Figure 2a,b). The entire process is carried out on a 10 cm 
diameter wafer, thus obtaining 20 chips in parallel after dicing. Chips based on the glass 
substrate are covered with a polydimethylsiloxane (PDMS) block to seal the microchannel 
and to provide in and outlets for the sample (see Figure 2c). Imaging of the sample is then 
performed through the 145 µm thick glass substrate. Chips based on the silicon substrate are 
covered with a microscopy cover slip containing a thin layer of PDMS through which the 
sample in the microchannel can be imaged (see Figure 2d). The chips are mounted on a 
fluorescence microscope for image acquisition of the diffusing nanoparticles. Laser light of 
640 nm is coupled into the waveguide using an optical fiber attached to a high precision 
alignment stage (see Supporting Information). 
 
Characterization of the light sheet 
Simulations of the fundamental propagating light mode show that such a planar waveguide is 
capable of producing a light sheet with a fairly uniform thickness over a large field of view, 
with a full width at half maximum (FWHM) of 4.6 µm at the waveguide exit, diverging to 7.5 
µm over a distance of 100 µm (see Supporting Information). The actual light sheet of both 
types of chips was characterized by acquiring a z-stack through the microchannel containing a 
dispersion of 0.2 µm fluorescent polystyrene nanospheres (for details, see Supporting 
Information). The light sheet intensity profile along the optical axis (i.e. perpendicular to the 
sheet of light) was calculated from the average intensity of the nanospheres visible in each 
frame of the z-stack (see Supporting Video 1). The average intensity profile across the entire 
microchannel width is shown in Figure 3a, resulting in an average thickness of ~9 µm 
FWHM. The smaller intensity peaks visible in the intensity profiles indicate that the 
waveguide is likely multimodal which could explain the slight difference with the theoretical 
calculations. 
 
Determining the contrast improvement 
The aim of light sheet illumination is to improve the contrast, which was quantified for both 
chips according to (Ip – Ib)⁄(Ip + Ib), with Ip the intensity of the nanoparticle and Ib the average 
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local background intensity 14. The microchannel was filled with a dispersion of 0.2 µm 
fluorescent polystyrene nanospheres containing various amounts of Cy5 dye to simulate 
different background intensities coming from free dye. As shown in Figure 3b, compared to 
classic epi-illumination, a contrast improvement of 1.5 - 2.4× was obtained in the glass chip, 
and 1.9 - 6.4× in the silicon chip, depending on the background intensity (see Supporting 
Information). This improvement approaches the performance of light sheet illumination as 
created with a high quality objective lens (see Figure 1a) 14. The better relative increase in 
contrast with the silicon chip is due to the light intensity almost going to zero at the edges of 
the light sheet, which is not the case for the glass chip (cfr. Figure 3a). However, in absolute 
terms the glass chip produced the best contrast as the silicon chip suffers from a higher 
background intensity due to the reflectivity of the silicon substrate (i.e. a doubling of the 
background intensity). 
 
Size and concentration measurements of cell-derived MVs 
In a next step, on-chip fSPT size and concentration measurements were performed of cell-
derived MVs isolated from the conditioned cell culture medium of breast cancer cells 28 (see 
Supporting Video 2). An excess of fluorescently labelled Annexin V was used to label the 
cell-derived MVs which are known to expose phosphatidylserine (PS) on their surface 13, 
followed by on-chip fSPT analysis without additional purification. As shown in Figure 4a, 
using sheet illumination, the majority of the MVs were situated in the 50 - 700 nm size range 
(in agreement with dynamic light scattering), and the overall number concentration was 8.4 · 
108 #/ml. Using conventional epi-fluorescence, a 4× lower concentration of only 1.9 · 108 
#/ml was found with a size distribution that is clearly shifted towards larger values. 
To demonstrate the potential of the microfluidic chip with integrated planar waveguide as a 
diagnostic tool, fSPT measurements were performed on cell-derived MVs secreted in the 
interstitial fluid harvested from fresh human breast cancer specimens 26. To ensure optimal 
fluorescent labelling of PS-exposing MVs present in the interstitial fluid, again an excess of 
dye-conjugated Annexin V was added. Subsequent on-chip fSPT analysis was performed 
without any additional purification steps to remove unbound label. A broad distribution of 
cell-derived MV sizes was found in the interstitial fluid, as shown in Figure 4b. The majority 
of the MVs are situated in the 90 - 900 nm size range, with a total number concentration of 
4.1 · 108 #/ml. Using conventional epi-fluorescence the background fluorescence was so high 
that only very few MVs were visible and no meaningful size distribution or concentration 
could be determined. This once more clearly demonstrates that improving contrast by light 
sheet illumination is essential for correct MV characterization, especially when there is a high 
background intensity due to out of focus particles and unbound fluorescent dye. 
 
Discussion and conclusion 
Here, we have produced a mass-manufacturable microfluidic chip with integrated light sheet 
illumination, and successfully demonstrated that it allows accurate fSPT size and 
concentration measurements of MVs in cell culture medium and in interstitial fluid collected 
from primary human breast tumours. The on-chip light sheet illumination was shown to allow 
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visualization of the small and dim MVs that are missed by the significant background present 
in conventional epi-fluorescence illumination. 
Nonetheless, further optimization of the chip’s performance should be possible. Based on the 
simulated light sheet created by the fundamental propagating light mode, it seems that at least 
30% reduction of the light sheet thickness should be possible by reducing the core thickness 
and fine-tuning of the refractive indices of core and cladding layers so as to obtain a 
monomodal waveguide. This requires optimization of the fabrication process, including the 
amount of D.E.R.™ 353 in the cladding layers, spin coating speeds, and baking times. In case 
of the silicon chip, contrast could be further improved by applying a non-reflective coating 
(e.g. black SU-8 formulations) on the silicon wafer before spin coating of the waveguide 
structure. Furthermore, automation of the coupling of light from the fiber into the waveguide 
is expected to make the chip more suitable for high-throughput measurements. 
Interestingly, one other type of microfluidic chip was recently reported for MV 
characterization in biological fluids based on labelling with magnetic nanoparticles and 
miniaturized nuclear magnetic resonance detection 7. Although it was shown to be capable of 
discriminating different types of MVs with high sensitivity, it does not feature independent 
size and concentration measurements. In contrast, the microfluidic chip presented here is 
much simpler in design, can be mass-fabricated at a low cost, and allows at the same time MV 
identification, as well as size and concentration measurements. Thus, it opens the possibility 
to be used as a diagnostic tool that combine low cost, ease of use, and sensitivity 29, 30. 
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Figure 1. Microfluidic chip with integrated waveguide for light sheet illumination. a) 
Illustration of the (green) excitation and (red) fluorescence light path in epi-fluorescence and 
light sheet illumination. The contrast for the nanoparticles in focus is better with light sheet 
illumination because the nanoparticles and unbound dye out of focus are not illuminated. b) 
Design of microfluidic chip with integrated waveguide for on-chip light sheet illumination. 
Laser light enters the planar waveguide by means of an optical fiber. While the laser light is 
confined in the vertical direction, it can spread horizontally in the waveguide so that a sheet of 
light emerges in the microchannel. The fluorescence light is collected by an objective lens 
whose focal plane coincides with the light sheet. The drawing is not to scale. 
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Figure 2. Photographs of the microfluidic chips with planar waveguide for light sheet 
illumination in a microchannel. a) Image of a silicon wafer with 20 planar waveguides and 
microchannels made from SU-8 after photolithography. b) Light microscopy image of a 
microfluidic chip showing the 100 µm wide microchannel. c) Image of microfluidic chip with 
glass substrate on top of a PDMS block. d) Image of microfluidic chip with silicon substrate 
covered with a microscope cover slip. 
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Figure 3. Experimental characterization of the light sheet and contrast. a) Average light sheet 
intensity profile along the optical axis of the microscope imaging lens. Contrary to epi-
fluorescence illumination (blue data points), illumination through the planar waveguide 
results in excitation light that is restricted to a thin region at the centre of the microchannel 
with a FWHM of ~9 µm (red data points). b) In order to determine the gain in contrast using 
light sheet illumination versus epi-fluorescence illumination, the microchannel is filled with a 
dispersion of 0.2 µm fluorescent polystyrene nanospheres. To mimic different values of 
background intensity, different concentrations of the red fluorescent dye Cy5 are added. 
Images are recorded using both illumination modes with the microscope focused at the centre 
of the light sheet. Example images obtained with a silicon chip are shown to the left. Contrast 
values for a range of Cy5 concentrations using the silicon and glass chip are shown to the 
right. The error bars represent the standard deviation. 
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Figure 4. On-chip fSPT concentration and size measurements of cell-derived membrane 
vesicles. a) fSPT size distribution and number concentration measurements are performed on 
cell-derived MVs in cell culture medium. The MVs are clearly visible when using light sheet 
illumination, while only a few particles are visible in conventional epi-fluorescence 
illumination mode due to the much higher background fluorescence. This results in a 4× 
underestimation of the number concentration and a bias towards larger (and brighter) MVs for 
epi-fluorescence illumination versus sheet illumination. b) Similar fSPT experiments are 
performed on MVs in patient derived interstitial fluid. The MVs are visible when using light 
sheet illumination, while almost no particles are visible in epi-fluorescence illumination mode. 
A meaningful concentration and size distribution could only be obtained when using sheet 
illumination. 
 
